Financial reports

Annual reports

2018, 2017, 2016, 2015, 2014, 2013

View all financial reports

15 November, 2019

INTERIM REPORT JANUARY – SEPTEMBER 2019

JULY – SEPTEMBER · Net sales amounted to MSEK 443.7 (395.3). This corresponds to an increase of 12% for the period, of which the acquired operations account for 10% (MSEK 41.0). · Adjusted EBITDA amounted to MSEK 156.9 (145.8) excluding non-recurring items, costs related to the acquisition of Trimb and restructuring costs totalling MSEK 28.2....

Read more
19 July, 2019

INTERIM REPORT JANUARY – JUNE 2019

THE PERIOD AND THE SECOND QUARTER

Read more
26 April, 2019

INTERIM REPORT THE FIRST QUARTER 2019

· Net sales amounted to MSEK 420.8 (267.1). This corresponds to an increase of 58%. The growth is attributable to products acquired during the period. · Net sales decreased by 6% compared to pro forma numbers for the same period 2018. At comparable exchange rates, sales decreased by 8%. The decrease in net sales is...

Read more
9 April, 2019

Karo Pharma publishes the 2018 annual report

Karo Pharma publishes its annual report for 2018. Today, on 9 April 2019, Karo Pharma is publishing its annual report for 2018 on the company’s website, www.karopharma.com (http://%20www.karopharma.com). FOR ADDITIONAL INFORMATION, PLEASE CONTACT: Mats-Olof Wallin, CFO, +4676 002 60 10, mats-olof.wallin@karopharma.se ABOUT KARO PHARMA Karo Pharma is a Specialty Pharma company, which develops and markets products for pharmacies...

Read more
14 February, 2019

YEAR-END REPORT 2018

FULL YEAR AND THE FOURTH QUARTER · Net sales amounted to MSEK 1,615.1 (657.6), of which the fourth quarter amounted to MSEK 463.3 (238.7). This corresponds to an increase of 146% for the full year, and 94% for the fourth quarter. A large part of the growth is attributable to products acquired during the period....

Read more